Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Moleculin Biotech CS (MBRX)

Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Moleculin Biotech CS 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 USA

www.moleculin.com P: 713-300-5160 F: 817-394-2127

Description:

Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company which focused on the development of anti-cancer drug candidates. The company's lead product candidate is Annamycin, a Phase II clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia. Moleculin Biotech, Inc. is based in Houston, TX.

Key Statistics

Overview:

Market Capitalization, $K 9,534
Enterprise Value, $K -14,016
Shares Outstanding, K 2,227
Annual Sales, $ 0 K
Annual Net Income, $ -29,770 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,270 K
EBIT, $ -29,500 K
EBITDA, $ -29,370 K
60-Month Beta 1.95
% of Insider Shareholders 6.70%
% of Institutional Shareholders 15.52%
Float, K 2,078
% Float 93.30%
Short Volume Ratio 0.50

Growth:

1-Year Return -69.48%
3-Year Return -91.85%
5-Year Return -94.83%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 67.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.85 on 11/13/23
Latest Earnings Date 05/09/24
Earnings Per Share ttm -10.05
EPS Growth vs. Prev Qtr 5.00%
EPS Growth vs. Prev Year 36.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 03/22/24

MBRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -80.91%
Return-on-Assets % -67.69%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.40
Book Value/Share 11.69
Interest Coverage -1.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar